Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
作者信息
Pratt C B, Epelman S, Jaffe N
出版信息
Cancer Treat Rep. 1987 Apr;71(4):421-3.
PMID:2435408
Abstract
摘要
相似文献
1
Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
Cancer Treat Rep. 1987 Apr;71(4):421-3.
2
[Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Bull Cancer. 2000 Feb;87(2):183-8.
3
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
J Clin Oncol. 2003 Apr 15;21(8):1574-80. doi: 10.1200/JCO.2003.08.165.
4
[The reproduction in France of Rosen's protocol for osteosarcomas].
Bull Cancer. 1988;75(2):201-6.
5
[Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1736-43.
6
[Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Bull Cancer. 1988;75(2):207-11.
7
Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Cancer Treat Res. 1993;62:287-91.
8
Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Med Pediatr Oncol. 1996 Aug;27(2):85-91. doi: 10.1002/(SICI)1096-911X(199608)27:2<85::AID-MPO4>3.0.CO;2-P.
9
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
J Clin Oncol. 2003 May 15;21(10):2011-8. doi: 10.1200/JCO.2003.08.132.
10
Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy.
J Clin Oncol. 1987 Aug;5(8):1185-90. doi: 10.1200/JCO.1987.5.8.1185.
引用本文的文献
1
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.
Pediatr Blood Cancer. 2016 Oct;63(10):1737-43. doi: 10.1002/pbc.26034. Epub 2016 Apr 29.
Zotero 插件